OUR MISSION
Accelerate the management and treatment of chronic disease at a community care setting resulting in fewer hospitals days.
OUR STORY
During the Covid-19 Pandemic, we witnessed firsthand the impact of reduced hospital access, especially on ‘Elderly’ chronic patients. Simple routine tasks such as Diabetic foot ulcer assessment and wound dressing change could not be performed, leaving many patients in a distressful situation. It also made us realize how ill-equipped the family caregivers and Primary care HCPs were to manage these routine diseases management tasks. Based upon this need, Longlive was born.
We established Longlive in June 2021. We have developed a prototype for our solution. The next step for us is to conduct 500 patient studies to validate and refine our solution before launching in the hands of those who need it the most.
Longlive is registered and based in London and is part of the Health Foundry London ecosystem, whilst our ambition is truly global!
£100,000
£1,000
£10,000
Join our community to view the full investment opportunity.
Already have an account?
OUR MISSION
Accelerate the management and treatment of chronic disease at a community care setting resulting in fewer hospitals days.
OUR STORY
During the Covid-19 Pandemic, we witnessed firsthand the impact of reduced hospital access, especially on ‘Elderly’ chronic patients. Simple routine tasks such as Diabetic foot ulcer assessment and wound dressing change could not be performed, leaving many patients in a distressful situation. It also made us realize how ill-equipped the family caregivers and Primary care HCPs were to manage these routine diseases management tasks. Based upon this need, Longlive was born.
We established Longlive in June 2021. We have developed a prototype for our solution. The next step for us is to conduct 500 patient studies to validate and refine our solution before launching in the hands of those who need it the most.
Longlive is registered and based in London and is part of the Health Foundry London ecosystem, whilst our ambition is truly global!
Potential Market size 2 billion users
Year 5 revenue forecast € 480 mln with ten mln user base
No Debt in the Company
Holistic health monitoring & coaching solution will empower every elderly and chronic patient(2 bln users) to live happier and healthier.
To achieve rapid adoption, a solution (smartwatch & app) is provided for free-yr 5 target 10 mln users.
Holistic health monitoring & coaching solution will empower every elderly and chronic patient(2 bln users) to live happier and healthier.
To achieve rapid adoption, a solution (smartwatch & app) is provided for free-yr 5 target 10 mln users.
Make new business connections when you want, as often as you want, from where you are, 24/7.
Chronic disease to cost $47 trillion by 2030: WEF
As the population worldwide is ageing, so is the cost of chronic care rising. Healthcare budgets are getting tighter, putting pressure on the Healthcare system worldwide.
There is a dire need to prevent and manage chronic disease at the community level, i.e. Family carers, GP & Community Nurse, Pharmacist etc.
We are looking at over 2 billion potential users for healthy ageing and chronic diseases patients combined.
We aim to capture 0.5% of this market by year and target 10 million users and looking for an exit.
Longlive a holistic solution that combines the world of sensors and credible healthcare content to offer real-time expert advice to Chronic disease patients.
Therefore let them live longer & happier lives.
Three core elements to our solution.
1) Smartwatch – captures 10 continuous data points.
2)App- Real-time expert advice and coaching.
3) Health AI.
We will offer our smartwatch and app free to users, and in return, we will generate revenue from two streams
– Commercialization of data with consent and incentive programs for:
Research & Development, Health Policy Researchers, Clinical Trials enrollment Real-world evidence and more…
– Highly Tailored Ads
Chronic Patient, Carers, HCPs are highly sought after profiles by:
Pharmaceutical, Online Pharmacies, Medical devices, Health Insurers
Tele-med.
We have already developed and tested the working prototype of both app and watch
Our Marketing strategy is based upon acquiring as many TG users as possible through strategic partnership models.
Our Sales strategy is to focus on the top 20 Multinational in the healthcare space, such as Pharmaceuticals, Medical devices & Health insurers.
We will also have an extensive PR budget, both on and offline.
Dr Julian Nesbitt is an ex A&E, now part time GP Doctor and NHS clinical entrepreneur at NHS England with wide experience in working in the NHS. He founded Dr Julian Medical Group and is the current CEO due to his passion to improve mental health access for the country. He has previously published original research and has a passion for governance and evidenced based results.
Investing in a startup involves risk, including loss of capital, lack of liquidity and dividends, and dilution, and should be done only as a part of a diversified portfolio. Please read our Capital at Risk Warning before investing. Please note that investments should be made by investors who understand and accept these risks, and tax treatment depends on individual circumstances and is subject to change at any time.
TrendScout does not provide legal, financial, tax or investment recommendations, and no communications from TrendScout, through this website or any other medium should be construed as such. Furthermore, nothing on this website shall be considered as an offer to sell or a solicitation of an offer to buy any equity, shares, or security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is illegal.
